NEGLECTED DISEASE RESEARCH & DEVELOPMENT: THE EBOLA EFFECT - - PowerPoint PPT Presentation

▶

Mar 08, 2023 33 likes •186 views

NEGLECTED DISEASE RESEARCH & DEVELOPMENT: THE EBOLA EFFECT POLICY CURES An independent non-profit research group Innovative ideas and rigorous analysis Focussed on R&D for neglected diseases of the developing world

SLIDE 1

NEGLECTED DISEASE RESEARCH & DEVELOPMENT: THE EBOLA EFFECT

SLIDE 2

POLICY CURES

An independent non-profit

research group

Innovative ideas and rigorous

analysis

Focussed on R&D for neglected

diseases of the developing world

SLIDE 3

Annual survey of global

neglected disease R&D funding

Neutral, comparable,

comprehensive analysis

Commissioned by the Bill &

Melinda Gates Foundation

G-FINDER OVERVIEW

SLIDE 4

35 neglected diseases (Ebola included)
142 product areas
All R&D stages
Data from 198 organisations
Over 9,300 entries
Reported in 2014 USD

G-FINDER SCOPE & METHODOLOGY

SLIDE 5

Findings OVERALL

$3,377m

Investment in neglected disease R&D in 2014

SLIDE 6

$150m

Findings OVERALL

Total funding 2007-2014 (US$, billions)

SLIDE 7

Findings DISEASES

2014 disease changes

Ebola Malaria Kinetoplastids TB Dengue Bacterial Pneumonia & meningitis Diarrhoeal diseases

SLIDE 8

Findings TOP FUNDERS

SLIDE 9

Findings FUNDERS

Largest industry contribution ever

SLIDE 10

Findings FUNDERS

2014 funding change – with Ebola 2014 funding change – without Ebola

Private Public Philanthropic

SLIDE 11

Discussion EBOLA

rapidly mobilised for Ebola R&D

$165m

Public Industry and philanthropic funders

SLIDE 12

drop in US Government non- Ebola R&D funding since 2009

$221m

Discussion PUBLIC FUNDING

Decline of US Government funding for non-Ebola R&D since 2009

SLIDE 13

Discussion INDUSTRY

2014 malaria R&D increase from industry

$51m

Industry investment 2007-2014

2014 HIV/AIDS R&D increase from industry

$33m

SLIDE 14

Discussion PDP FUNDING

increase in 2014

$42m

SLIDE 15

Download the report at www.policycures.org/g-finder2015.html